Biotest GmbH KGaA (LTS:0N6Z) Probability of Financial Distress (%)


What is Biotest GmbH KGaA Probability of Financial Distress (%)?

Biotest GmbH KGaA does not have enough data to calculate Probability of Financial Distress (%).

Biotest GmbH KGaA  (LTS:0N6Z) Probability of Financial Distress (%) Explanation

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk in the upcoming year. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.

Biotest GmbH KGaA Probability of Financial Distress (%) Related Terms

Biotest GmbH KGaA Probability of Financial Distress (%) Historical Data

* Premium members only.

The historical data trend for Biotest GmbH KGaA's Probability of Financial Distress (%) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest GmbH KGaA Probability of Financial Distress (%) Chart

Biotest GmbH KGaA Annual Data
Trend
Probability of Financial Distress (%)

Biotest GmbH KGaA Semi-Annual Data
Probability of Financial Distress (%)

LTS:0N6Z vs : Probability of Financial Distress (%) Comparison

For the Biotechnology subindustry, Biotest GmbH KGaA's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotest GmbH KGaA Probability of Financial Distress (%) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotest GmbH KGaA's Probability of Financial Distress (%) distribution charts can be found below:

* The bar in red indicates where Biotest GmbH KGaA's Probability of Financial Distress (%) falls into.


Biotest GmbH KGaA Business Description

Comparable Companies
Biotest GmbH & Co KGaA is a specialist in haematology, clinical immunology, and intensive care medicine. The group develops, manufactures, and markets plasma proteins and biotherapeutic drugs. The group's value chain extends from pre-clinical and clinical development to world-wide marketing and distribution. It manufactures immunoglobulins, clotting factors, and albumins, which are derived from human blood plasma. The group markets its products in Europe, the Middle East, China, Australia, Africa, and the USA.